A digital view of the world illustrates how Astellas is a global company committed to serving patients worldwide.

News

Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.

Month Year

Month Year

Aug 4, 2009

AstraZeneca and Astellas Announce Co-Promotion Alliance for the Inhalant Combination Drug of Budesonide and Formoterol (generic names) for the Treatment of Asthma in Japan

Tokyo, Japan, August 4, 2009 - AstraZeneca K.K., the Japanese subsidiary of AstraZeneca PLC and Astellas Pharma Inc. (“Astellas”) today announced that AstraZeneca AB (“AstraZeneca”) and...

Read more
Aug 3, 2009

Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved SumavelTM DoseProTM -- Novel Product Recently Approved by the FDA for Treatment of Acute Migraine and Cluster Headache --

Read more
Jul 21, 2009

ASTELLAS ESTABLISHES AFFILIATE IN BRAZIL　Sao Paulo office opening completes expansion into BRIC markets

Tokyo, Japan, July 20, 2009, Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced today that it has established Astellas Farma Brasil...

Read more
Jul 13, 2009

DATA ON GASTER® SHOW PREVENTION OF PEPTIC ULCERS IN USERS OF LOW-DOSE ASPIRINE - "FAMOUS trial" reported in The Lancet -

Tokyo, Japan, July 13, 2009 - Astellas Pharma Inc. (“Astellas”; Headquarters: Tokyo; President and CEO: Masafumi Nogimori)today announced that the FAMOUS (Famotidine for the Prevention of Peptic U

Read more
Jul 8, 2009

Contents of Stock Acquisition Rights (Stock Option Scheme as Stock-Linked Compensation Plan

Read more

Show per page

Discover more

Return to media homepage

Follow us

Subscribe to news alerts